VRML Share Price

Open 1.57 Change Price %
High 1.60 1 Day 0.00 0.00
Low 1.53 1 Week 0.00 0.00
Close 1.59 1 Month -0.31 -16.32
Volume 19893 1 Year 0.23 16.91
52 Week High 2.85
52 Week Low 0.76
VRML Important Levels
Resistance 2 1.65
Resistance 1 1.63
Pivot 1.57
Support 1 1.55
Support 2 1.53
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
QQQ 143.96 -0.63%
SIRI 5.83 8.16%
FB 170.44 2.92%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SHOR 7.50 28.21%
OPNT 14.53 27.46%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
LPSN 13.50 18.42%
TREE 217.15 18.14%
AXTI 8.80 15.79%
DRYS 1.20 15.38%
More..
NASDAQ USA Top Losers Stocks
EDMC 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
IPCI 1.36 -45.38%
DVOX 0.05 -44.44%
GLCH 0.70 -44.00%
More..

Vermillion, Inc. (NASDAQ: VRML)

VRML Technical Analysis 2
As on 27th Jul 2017 VRML Share Price closed @ 1.59 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.55 & Strong Sell for SHORT-TERM with Stoploss of 1.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
VRML Target for July
1st Target up-side 2.1
2nd Target up-side 2.28
3rd Target up-side 2.47
1st Target down-side 1.58
2nd Target down-side 1.4
3rd Target down-side 1.21
VRML Other Details
Segment EQ
Market Capital 18049096.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.vermillion.com
VRML Address
VRML
Building III
Suite 100
Austin, TX 78738
United States
Phone: 512-519-0400
Fax: 512-439-6980
VRML Latest News
Stocks Rolling Backwards Pre-Bell, Looking for a Reversal: Vermillion, Inc ...   Geneva Journal   - 27th Jul 17
Looking For a Catalyst: Update on Vermillion, Inc. (NASDAQ:VRML)   FLBC News   - 27th Jul 17
HighTower Advisors LLC Sells 89700 Shares of Vermillion, Inc. (NASDAQ:VRML)   Stock Observer   - 27th Jul 17
Buyers and Sellers Alert -: Vermillion, Inc. (VRML)   Hot Stocks Point   - 17th Jul 17
Vermillion Reports First Quarter 2017 Results   PR Newswire (press release)   - 11th May 17
Vermillion Announces Publication of Ovarian Cancer Symptoms Index Study   PR Newswire (press release)   - 29th Mar 17
Vermillion Announces Equity Financing of $5.6 Million   PR Newswire (press release)   - 14th Feb 17
ASPiRA LABS' OVA1 Technology Receives "Level B" Recommendation in the Latest ...   PR Newswire (press release)   - 10th Nov 16
Vermillion and ASPiRA LABs Applaud the FDA's Position on Ovarian Cancer Screening   PR Newswire (press release)   - 09th Sep 16
Vermillion Announces FDA Clearance of Overa®, Second Generation OVA1® Test   PR Newswire (press release)   - 21st Mar 16
Interactive Technical Analysis Chart Vermillion, Inc. ( VRML NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Vermillion, Inc.
VRML Business Profile
Vermillion, Inc. is engaged in the discovery, development and commercialization of diagnostic tests that helps physicians diagnose, treat and improve outcomes for patients. The Company's tests are intended to help guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. The Company combines multiple biomarkers into a single, reportable index score. The Company concentrates its development of diagnostic tests in the fields of oncology, cardiology and women�s health, with the initial focuses on ovarian cancer.The Company's product, OVA1, addresses a clear unmet clinical need, namely the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor.In addition to OVA1, the Company has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease.